Companies: 10,795·Total market cap: $144.5T
CanSino Biologics Inc.

CanSino Biologics Inc.

CASBFOTCHealthcare● Active
$3.97
+$0.97(+32.33%)
Market Cap$1.4B
P/E Ratio—
52W High$6.99
52W Low$3
Overview
Stock ranking:Drug Manufacturers - Specialty & Generic·Healthcare·View All Market Cap Rankings →

CanSino Biologics Inc. (CASBF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CASBF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.01casbf eps ttm · casbf earnings per shareEarnings history
PE Ratio (TTM)—casbf pe ratio ttm · casbf price to earningsPE Ratio deep dive
Revenue (TTM)$1.1Bcasbf revenue ttm · casbf annual revenueFull revenue history
Dividend Yield1.27%does casbf pay dividends · casbf dividend yieldDividend history
Shares Outstanding253.4Mcasbf shares outstanding · casbf floatShares outstanding history
Next EarningsAug 21, 2026Est.casbf earnings date · casbf next earningsEarnings history

Explore CanSino Biologics Inc. Data

casbf stock data · financials
Market Cap$1.4Bcasbf market cap · casbf valuation
Analyst Forecast—
Dividends1.27%does cansino biologics inc. pay dividends · casbf dividend yield
Revenue$1.0B+25.12%cansino biologics inc. annual revenue · casbf revenue
EarningsEPS $0.11+107.19%casbf earnings · casbf eps
PE Ratio—casbf pe ratio · casbf price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$1.03B▲ +25.12% YoY
202320242025
cansino biologics inc. revenue · casbf revenue 2025
FY 2025Net Income$27.2M▲ +107.17% YoY
202320242025
cansino biologics inc. net income · casbf profit 2025
FY 2025EPS$0.11▲ +107.19% YoY
202320242025
casbf eps · cansino biologics inc. earnings per share 2025
TTM:Revenue: $1.11BNet Income: -$836081.00EPS: $-0.01View income statement →

Stock Performance

Full History
1D+3.33%
1W+3.33%
1M-19.69%
3M-19.69%
YTD-34.60%
1Y-3.13%
5Y-93.02%

About CanSino Biologics Inc.

CEOXuefeng Yu
IPO DateJan 2, 2020
Employees1,105
CountryCN
Websitecansinotech.com

CanSino Biologics Inc. is a Chinese biotechnology company dedicated to the research, development, manufacturing, and marketing of vaccines within the People's Republic of China. The company's current …

Drug Manufacturers - Specialty & GenericHealthcareOTCCN

what is cansino biologics inc. · casbf stock overview · cansino biologics inc. company profile · who is cansino biologics inc. ceo · casbf OTC · cansino biologics inc. headquarters · cansino biologics inc. business segments

About Stock Overview & Key Data

CanSino Biologics Inc. (CASBF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 2, 2020. As of the latest trading session, CASBF stock price is $3.97, with a market capitalization of $1.4B. The stock has returned -3.13% over the past 12 months and -34.60% year-to-date.

In fiscal year 2025, CanSino Biologics Inc. reported revenue of $1.0B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CanSino Biologics Inc. (CASBF) stock price is $3.97. The stock is traded on OTC under the ticker symbol CASBF. The 52-week range is $3.00 – $6.99.

CASBF stock priceCASBF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice